FDA Fast Track
FDA Fast Track is a program to accelerate the development, review, and approval of new drugs to fill an unmet medical need, such as treatment for metastatic...
Read MoreCell-Based Therapies: A Type of Immunotherapy for MBC
Immunotherapy is a type of treatment for MBC that increases the immune system’s ability to kill cancer cells. Many immunotherapy treatments are drugs. However,...
Read MoreBlack Breast Cancer & BRCA1/2 Mutations
Knowing if you have an inherited (also called genetic) BRCA1 or BRCA2 mutation is a vital part of treatment planning for people diagnosed with breast cancer...
Read MoreImmunotherapy Resistance
Researchers have made tremendous progress on cancer immunotherapy in the last decade. Immune checkpoint inhibitor drugs, adoptive cell therapies, and tumor...
Read MoreModernizing Clinical Trials
The COVID-19 pandemic has impacted every aspect of the clinical trial process. However, it has also brought opportunities to modernize clinical trials. Read below...
Read MoreUpdate on Oral SERDs for Estrogen Receptor-Positive MBC
Selective estrogen receptor degraders (SERDs) are a type of hormone therapy used to treat estrogen receptor-positive (ER+) MBC. Oral SERDs are taken by mouth....
Read MoreMBC News from 2021 AACR Meeting
The American Association for Cancer Research (AACR) is the largest cancer research organization dedicated to accelerating research to prevent and cure cancer. The...
Read MoreVideos About Breast Cancer Clinical Trials
Many of our Metastatic Trial Search partners provide information about clinical trials to help people in the metastatic breast cancer community understand all...
Read MoreLymphodepletion in Cancer Immunotherapy
Adoptive cell therapy (ACT) is a category of immunotherapy currently being studied in clinical trials to treat metastatic breast cancer. Types of ACT...
Read MoreSEARCH OUR SITE
for past articles or specific information.